小鼠模型中触珠蛋白与血红素结合蛋白缺乏对志贺毒素诱导溶血性尿毒症综合征疾病进展的不同作用
该研究在小鼠HUS样模型中观察触珠蛋白和血红素结合蛋白缺乏及触珠蛋白治疗的影响。触珠蛋白缺乏小鼠7天生存率25%低于野生型71.4%,而血红素结合蛋白缺乏小鼠全部存活且肾脏炎症和血栓性微血管病减轻。低剂量触珠蛋白治疗减轻野生型小鼠肾脏血小板沉积和中性粒细胞募集,提示触珠蛋白参与HUS病理消退而血红素结合蛋白作用冗余。
要点
- 触珠蛋白缺乏小鼠7天生存率25%,低于野生型小鼠的71.4%。
- 血红素结合蛋白缺乏小鼠在志贺毒素攻击后全部存活,肾脏炎症和血栓性微血管病减轻。
- 低剂量触珠蛋白治疗减轻志贺毒素攻击野生型小鼠的肾脏血小板沉积和中性粒细胞募集。
核心结论
- 触珠蛋白和血红素结合蛋白缺乏在志贺毒素介导的HUS中发挥不同作用,提示触珠蛋白参与HUS病理消退而血红素结合蛋白作用冗余。
研究设计与样本
- 研究采用小鼠HUS样疾病模型,比较触珠蛋白缺乏(haptoglobin-/-)、血红素结合蛋白缺乏(hemopexin-/-)及野生型小鼠在志贺毒素攻击后的表现,并评估低剂量触珠蛋白治疗野生型小鼠的效果。
主要发现
- 触珠蛋白缺乏小鼠7天生存率为25%,低于野生型小鼠的71.4%;血红素结合蛋白缺乏小鼠全部存活。
- 志贺毒素攻击的血红素结合蛋白缺乏小鼠肾脏炎症减轻、血栓性微血管病减轻,表现为中性粒细胞募集和血小板沉积减少,并伴有超常的血浆触珠蛋白水平。
- 低剂量触珠蛋白给予志贺毒素攻击的野生型小鼠可减轻肾脏血小板沉积和中性粒细胞募集。
- 志贺毒素攻击的野生型和触珠蛋白缺乏小鼠溶血替代指标升高,但肝脏血红蛋白降解标志物血红素加氧酶-1、铁蛋白和CD163表达仅在志贺毒素攻击的野生型小鼠中增加。
- 触珠蛋白缺乏小鼠显示肾小管铁沉积,作为肾脏血红蛋白降解的指标。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Thrombotic microangiopathy, hemolysis and acute kidney injury are typical clinical characteristics of hemolytic-uremic syndrome (HUS), which is predominantly caused by Shiga-toxin-producing Escherichia coli. Free heme aggravates organ damage in life-threatening infections, even with a low degree of systemic hemolysis. Therefore, we hypothesized that the presence of the hemoglobin- and the heme-scavenging proteins, haptoglobin and hemopexin, respectively impacts outcome and kidney pathology in HUS. Here, we investigated the effect of haptoglobin and hemopexin deficiency (haptoglobin-/-, hemopexin-/-) and haptoglobin treatment in a murine model of HUS-like disease. Seven-day survival was decreased in haptoglobin-/- (25%) compared to wild type mice (71.4%), whereas all hemopexin-/- mice survived. Shiga-toxin-challenged hemopexin-/- mice showed decreased kidney inflammation and attenuated thrombotic microangiopathy, indicated by reduced neutrophil recruitment and platelet deposition. These observations were associated with supranormal haptoglobin plasma levels in hemopexin-/- mice. Low dose haptoglobin administration to Shiga-toxin-challenged wild type mice attenuated kidney platelet deposition and neutrophil recruitment, suggesting that haptoglobin at least partially contributes to the beneficial effects. Surrogate parameters of hemolysis were elevated in Shiga-toxin-challenged wild type and haptoglobin-/- mice, while signs for hepatic hemoglobin degradation like heme oxygenase-1, ferritin and CD163 expression were only increased in Shiga-toxin-challenged wild type mice. In line with this observation, haptoglobin-/- mice displayed tubular iron deposition as an indicator for kidney hemoglobin degradation. Thus, haptoglobin and hemopexin deficiency plays divergent roles in Shiga-toxin-mediated HUS, suggesting haptoglobin is involved and hemopexin is redundant for the resolution of HUS pathology.
引用
- Pirschel W, Mestekemper AN, Wissuwa B, et al. Divergent roles of haptoglobin and hemopexin deficiency for disease progression of Shiga-toxin-induced hemolytic-uremic syndrome in mice. Kidney Int. 2022. PMID: 35031328. doi:10.1016/j.kint.2021.12.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。